Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy

Kirsten rat sarcoma virus oncogene homolog (KRAS) mutant lung cancer remains a challenge to cure and chemotherapy is the current standard treatment in the clinic. Hence, understanding molecular mechanisms underlying the sensitivity of KRAS mutant lung cancer to chemotherapy could help uncover unique...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Lett
Main Authors: Tian, Danmei, Tang, Jinshan, Geng, Xinran, Li, Qingwen, Wang, Fangfang, Zhao, Huadong, Narla, Goutham, Yao, Xinsheng, Zhang, Youwei
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8293908/
https://ncbi.nlm.nih.gov/pubmed/32814087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2020.08.008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares